Clinical Trial: Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult Volunteers

U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07598968) titled 'Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of HL1113-R1 and HL1113-R2 in Healthy Adult Volunteers' on April 13.

Brief Summary: This clinical trial is a two-arm, open-label, single-sequence, multiple oral dosings, cross-over design clinical trial to evaluate the safety and pharmacokinetic characteristics of HL1113-R1 and HL1113-R2 in healthy adult volunteers

Study Start Date: June 18, 2023

Study Type: INTERVENTIONAL

Condition: Hypertension Diabete Type 2

Intervention: DRUG: Test group 1

* Period 1: HL1113-R1, once daily, administered for 7 days

* Period 2: HL1113-R1 + HL1113-R2 once daily, admini...